- In April 2024, Clarapath, a medical robotics company, announced a strategic collaboration with Mayo Clinic to propel a new era of laboratory automation. This partnership aims to enhance the efficiency and accuracy of anatomic pathology workflows through advanced automation technologies
- In May 2024, Indica Labs received FDA clearance for its HALO AP Dx digital pathology platform. This approval marks a significant milestone in the adoption of digital pathology solutions, enabling pathologists to analyze digital slides with improved precision and efficiency
- In September 2023, Lab Genomics USA, a subsidiary of Lab Genomics Co., Ltd., announced the acquisition of QDx Pathology, a leader in molecular and diagnostic pathology. This acquisition is anticipated to significantly impact the firm's capabilities and the broader industry's future by expanding molecular diagnostic services
- In March 2023, PathAI introduced the Aim-PDL1 algorithm and digital pathology platform for non-small cell lung cancer (NSCLC) in collaboration with 13 top academic medical facilities, health systems, independent pathology institutions, and reference laboratories nationwide. This initiative aims to enhance diagnostic accuracy and streamline pathology workflows through AI integration
- In February 2022, GlobalMedia Group, LLC achieved the CE mark for its ClinicalAccess Station Lite, the eNcounter telehealth software suite, and other diagnostic examination cameras. This regulatory approval allows the company to expand its telepathology services within the European Union, improving access to pathology diagnostics in remote areas
